Table 2.

Disease activity over time among patients undergoing VDZ therapy.

Disease Activity	Time
	0 mo	3 mo	6 mo	9 mo	12 mo
UC
Mayo score	137, 9.20 ± 2.27	116, 4.68 ± 2.71a	58, 3.71 ± 2.41a	54, 3.59 ± 2.68a	37, 4.35 ± 3.45a
CD
CDAI	127, 241 ± 89.5	108, 178 ± 87.3a	84, 157 ± 90.7a	66, 142 ± 98.5a	56, 124 ± 93.9a

Values are n, mean ± SD.

Abbreviations: CD, Crohn’s disease; CDAI, Crohn’s Disease Activity Index; UC, ulcerative colitis; VDZ, vedolizumab.

^a P < .001, in comparison with baseline.